Tutti i video
Severe asthma: results of the ANANCHE real‑life study on benralizumab
it
Prof. Giorgio Walter Canonica
ERS–EULAR guidelines on interstitial lung disease associated with connective tissue disease
en
Prof. Bruno Crestani
“Per Corsa” initiative promotes prevention of respiratory diseases and early diagnosis
it
Tiziana Nicoletti
Asthma, monoclonal antibodies radically change the approach to therapy
it
Prof. Giorgio Walter Canonica
The “teleconsultation” between GP and pulmonologist to speed up diagnosis and treatment
it
Dr. Raffaele Scala
COPD in exacerbation, prospects for new biological therapeutic interventions
it
Prof. Alberto Papi
Reducing the social impact of COPD with preventive diagnostic strategy
it
Prof. Paola Rogliani
Idiopathic pulmonary fibrosis, new effective drugs are on the way
it
Prof. Luca Richeldi
Pneumococcal vaccine: the role of your GP
it
Prof. Francesco Blasi
Asthma: with biological drugs, it is possible to personalize diagnosis and therapy
it
Prof. Giorgio Walter Canonica
Asthma, new paradigm: inhaled steroid + bronchodilator in on-demand treatment
it
Prof. Alberto Papi
Tecniche non invasive nell'insufficienza respiratoria
it
Dr. Raffaele Scala
The treatment and management of severe asthma
en
Prof. Eugene R. Bleecker
Diseases caused by Pneumococcal bacteria
it
Prof. Francesco Blasi
Evidence on risk factors for idiopathic pulmonary fibrosis
it
Prof. Isabella Annesi Maisano
Health education is essential in the management of respiratory diseases
it
Prof. Stefano Centanni
Management of chronic respiratory diseases according to AIPO - ITS
it
Dr. Raffaele Scala
The therapeutic scenario in severe asthma, between biological drugs and biosimilars
it
Prof. Giorgio Walter Canonica
Refractory cough due to dysregulation of sensitive nerve fibers
it
Prof. Federico Lavorini
BPCO, saperne di più per affrontarla meglio
it
Prof. Francesco Blasi
Epidemiology, risk groups
it
Prof. Francesco Blasi
Pneumococcal disease recovering after contraction in the Covid period
it
Prof. Susanna Esposito
Cardiovascular comorbidities and the use of biologics in COPD patients
it
Prof. Antonio Spanevello
Gender medicine in respiratory diseases and in the definition of care pathways
it
Prof. Elena Bargagli
Stop al fumo contro accelerazione della BPCO
it
Prof. Francesco Blasi
Reimbursement of anti-smoking drugs is needed to combat the e-cigarette emergency
it
Dr. Roberto Boffi
Chronic cough: new treatments in advanced stages
en
Prof. Lorcan McGarvey
Asthma: patient oriented inhalers and treatment efficacy
en
Prof. Alberto Papi
Asma: terapia più efficace se device orientato al paziente
it
Prof. Alberto Papi
Lung lymphomas: the range of available therapeutic solutions
it
Prof. Venerino Poletti
COPD stability as a new therapeutic target
it
Prof. Fulvio Braido
Bronchiectasis: the benefits of high humidified flow
it
Dr. Giuseppe Fiorentino
Asma e BPCO: la corretta terapia migliora la prognosi
it
Prof. Francesco Blasi
Outcome variables that are influenced by long-term ventilation
en
Prof. Anita Simonds
Respiratory diseases: preventing avoidable risk factors
it
Dr. Giovanni Viegi
Bronchial asthma: poor adherence to steroid therapy, what are the consequences?
it
Dr. Claudio Micheletto
Sarcoidosis: complexities in diagnosis and therapy
it
Prof. Paolo Spagnolo
L'impegno educativo del medico è la chiave del successo della terapia
it
Prof. Francesco Blasi
Raise awareness of the risks of pollutants to children's respiratory health
it
Dr. Stefania La Grutta
Lung cancer screening with low-dose CT reduces mortality
it
Prof. Michele Mondoni
L'apnea ostruttiva del sonno in Anestesiologia e Terapia intensiva
it
Prof. Paolo Navalesi
Pulmonary Arterial Hypertension: Understanding Today’s Patient Population
Dr Luke S. Howard
Progressive interstitial lung diseases: importance of early diagnosis and treatment
it
Prof. Paolo Spagnolo
Obstructive sleep apnea in Anesthesiology and IC
en
Prof. Paolo Navalesi
Use of home telemedicine in mechanical ventilation. ERS guidelines.
it
Prof. Claudia Crimi
State of the art in bronchiectasis management
it
Prof. Andrea Gramegna
COPD Home Ventil.: proper management advantages
en
Dr. Raffaele Scala
Gestione appropriata della ventilazione meccanica nella BPCO
it
Dr. Raffaele Scala
Benralizumab in severe asthma: clinical remission exceeds three years
it
Dr. Paolo Cameli
Metabolic dysfunction and respiratory diseases
en
Prof. Ian M. Adcock
Chronic Respiratory Failure: Telemonitoring and Telemedicine to Improve Treatment
en
Dr. Maxime Patout
Tezepelumab in severe uncontrolled asthma, evolution towards “disease modifying” therapy
it
Dr. Francesco Pelaia
Immuno-Oncology: new pathways, new targets
en
Prof. Joachim G. Aerts
Female and adolescent smoking: what strategies can be used to combat it?
it
Dr. Roberto Boffi
Lung cancer immunotherapy
en
Prof. Anne-Marie Dingemans
European Lung Foundation, a reference for patients with respiratory diseases
en
Pippa Powell
Biological drugs, new perspectives for use in eosinophilic COPD
it
Dr. Claudio Micheletto
Obstructive sleep apnea
en
Prof. Eva Lindberg
Chronic noninvasive ventilation in COPD: take-home message
en
Prof. Wolfram Windisch
Turkey: the importance of cooperation with European pneumology
en
Prof. Hasan Bayram
BPCO e comorbidità cardiovascolari
it
Dr. Mario Del Donno
Noninvasive ventilation in stable hypercapnic COPD
en
Prof. Marieke Duiverman
Idiopatic pulmonary fibrosis: combining drugs may improve prognosis
en
Prof. Carlo Vancheri
Fibrosi polmonare idiopatica: prognosi migliore con combinazione di farmaci
it
Prof. Carlo Vancheri